Skip to content

Independent evidence reviews · Free · No referral fees

SaunaJoints & musculoskeletal

Sauna for ankylosing spondylitis / axial spondyloarthritis

Evidence review

Grade B· Moderate7 studiesLast reviewed November 8, 2026Also reviewed: cold therapy (grade C)

Overview

In a German randomized trial of 35 inpatients with ankylosing spondylitis, adding six sessions of water-filtered infrared-A whole-body hyperthermia (a clinic radiant-heat device) to physical therapy gave greater pain relief, less analgesic use and improvements in BASDAI and BASFI lasting up to 3-6 months, while HAQ did not change. In a small infrared-sauna pilot, pain and stiffness fell during sessions without increased disease activity. A randomized spa-exercise program that included sauna at one site improved a pooled symptom index at 4 weeks, but sauna's own contribution is unknown. Mechanistic studies report lower pro-inflammatory cytokines after whole-body hyperthermia and no cortisol or lymphocyte change after a single hot bath.

Key findings

  • RCT, n=35 inpatients: 6 sessions of water-filtered infrared-A whole-body hyperthermia added to physical therapy gave significantly greater pain relief than physical therapy alone, with BASDAI and BASFI improving only in the hyperthermia group (up to 6 and 3 months); HAQ unchanged in both groups (Lange 2017)
  • Infrared sauna, 8 sessions over 4 weeks (n=17 AS): pain and stiffness fell significantly during sessions (p<0.001); 4-week changes not statistically significant; no disease flare (Oosterveld 2009)
  • RCT, n=120: 3-week spa-exercise therapy (one arm including sauna) vs usual care; pooled index of change difference 0.46 (95% CI 0.15-0.78) at week 4 for the sauna-site arm, 0.34 (95% CI -0.05 to 0.73) at week 16 (van Tubergen 2001)
  • Mild whole-body hyperthermia, 9 cycles (n=12 AS): TNF-alpha, IL-1beta and IL-6 reduced by 40-50% (Tarner 2009)
  • Single 50-minute hot bath to 101.3 F body temperature (12 AS, 12 healthy): no change in cortisol or lymphocyte subsets (Lange 2005)
  • Controlled study of whole-body hyperthermia in AS: reduced blood viscosity and analgesic use and improved mobility reported, without numbers in the abstract (Matrai 1991)

Every study we reviewed

3 mixed results · 3 found benefit · 1 found no effect

Each study was checked on PubMed. The colored edge shows the direction of the result. The research library lists 23 studies on ankylosing spondylitis, across all heat and cold therapies, including case reports and older work not graded here.

[1]Pilot / uncontrolled studyn = 34Mixed

Infrared sauna in patients with rheumatoid arthritis and ankylosing spondylitis. A pilot study showing good tolerance, short-term improvement of pain and stiffness, and a trend towards long-term beneficial effects.

Oosterveld FG et al. Clin Rheumatol. 2009. PubMed 18685882 · DOI · Free full text

Who
17 patients with ankylosing spondylitis and 17 with rheumatoid arthritis (Netherlands)
What
Infrared sauna, series of 8 treatments over 4 weeks
Protocol
2/wk · 4 wk
Measured
Pain, stiffness, fatigue, disease activity
Result
AS subgroup (n=17): pain and stiffness decreased significantly during an IR session (p<0.001); improvements over the 4-week period clinically relevant but not statistically significant; no relevant change in disease activity; no adverse effects
Limitations
Uncontrolled pilot; 17 AS patients; abstract-level data
[2]Randomized controlled trialn = 120Mixed

Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial.

van Tubergen A et al. Arthritis Rheum. 2001. PubMed 11642642 · DOI

Who
Dutch outpatients with ankylosing spondylitis
What
3-week spa-exercise therapy (group exercise, walking, hydrotherapy, sports, plus sauna at the Dutch site or radon-gallery visits at the Austrian site) vs usual drugs and weekly group physiotherapy
Protocol
3 wk
Measured
Pooled index of change (function, global well-being, pain, morning stiffness)
Result
Sauna-site arm vs control: mean PIC difference 0.46 (95% CI 0.15-0.78, p=0.005) at week 4 and 0.34 (95% CI -0.05 to 0.73, p=0.086) at week 16; no difference at weeks 28 and 40
Limitations
Multicomponent intervention; sauna effect cannot be isolated; unblinded
[3]Pilot / uncontrolled studyn = 24Benefit

The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis.

Tarner IH et al. Clin Rheumatol. 2009. PubMed 19089489 · DOI

Who
12 men with ankylosing spondylitis and 12 healthy controls (Germany)
What
Mild whole-body hyperthermia, 9 cycles
Protocol
101.3 core target °F · 50 min
Measured
Serum TNF-alpha, IL-1beta, IL-6
Result
In AS patients hyperthermia reduced all three cytokines by 40-50%
Limitations
Mechanistic outcome only; no clinical endpoints in abstract; men with clinically inactive AS; hyperthermia device, not sauna
[4]Pilot / uncontrolled studyn = 16Mixed

Whole body hyperthermia treatment increases interleukin 10 and toll-like receptor 4 expression in patients with ankylosing spondylitis: a pilot study.

Zauner D et al. Int J Hyperthermia. 2014. PubMed 25256892 · DOI · Free full text

Who
6 AS patients and 10 healthy controls (Austria)
What
Single moderate whole-body hyperthermia session
Protocol
101.7-102.2 core °F · 60 min · 1/wk
Measured
Immune gene expression, cytokines, acute phase reactants
Result
IL-10, TLR-4 and HSPB1 expression rose up to 3 h after treatment; no significant change in systemic cytokine concentrations or acute phase reactants
Limitations
Six patients; single session; mechanistic outcomes only
[5]Controlled trial (not randomized)Benefit

[Hemorheologic and clinical changes in ankylosing spondylitis during hyperthermia].

Matrai A et al. Acta Med Austriaca. 1991. PubMed 1796724

Who
Patients with ankylosing spondylitis (Austria)
What
Whole-body hyperthermia (clinic-delivered), not a sauna
Measured
Blood and plasma viscosity, red cell deformability, analgesic use, mobility, well-being
Result
Authors report reduced blood and plasma viscosity, normalized red cell deformability, reduced analgesic use, increased mobility and improved well-being; no numbers in abstract
Limitations
German-language; sample size, protocol and statistics not in abstract; hyperthermia, not sauna
[6]Randomized controlled trialn = 35Benefit

Effect of iterative whole-body hyperthermia with water-filtered infrared-A radiation in ankylosing spondylitis: a controlled, randomized, prospective study

Lange U et al. Aktuelle Rheumatologie. 2017. Not in PubMed: source · DOIGerman publication; title and summary translated by SaunaLMN. Original title: Wirkung iterativer Ganzkörperhyperthermie mit wassergefilterter Infrarot-A-Strahlung bei ankylosierender Spondylitis – eine kontrollierte, randomisierte, prospektive Studie

Who
Hospital inpatients with ankylosing spondylitis (Germany); medication comparable between groups
What
Whole-body hyperthermia with water-filtered infrared-A radiation (clinic radiant-heat device, not a sauna), 6 sessions, added to standardized physical therapy (n=20) vs standardized physical therapy alone (n=15)
Measured
Pain (VAS), BASDAI, BASFI, HAQ, FFbH, ESR, CRP, TNF-alpha, IL-1beta, IL-6; follow-up to 3 months (6 months in the hyperthermia group)
Result
Pain relief significantly greater with hyperthermia than control over follow-up, with reduced NSAID/analgesic use; BASDAI and BASFI fell significantly only in the hyperthermia group (lasting up to 6 and 3 months); FFbH improved at 3 months vs baseline; HAQ did not improve significantly in either group; ESR fell in the hyperthermia group; TNF-alpha and IL-1beta fell at 3 months (TNF-alpha also fell in controls); IL-6 unchanged. No effect sizes in the abstract
Limitations
Small (n=35), unblinded, no sham; German-language abstract (translated by us); between-group effect sizes not reported; 6-month data collected in the hyperthermia group only; clinic hyperthermia device rather than a sauna
[7]Pilot / uncontrolled studyn = 24No effect

Effect of mild hyperthermia on blood levels of cortisol and lymphocyte subpopulations in patients with ankylosing spondylitis and in healthy people

Lange U et al. Physikalische Medizin, Rehabilitationsmedizin, Kurortmedizin. 2005. Not in PubMed: source · DOIGerman publication; title and summary translated by SaunaLMN. Original title: Einfluss der milden Hyperthermie auf die Blutspiegel von Kortisol und Lymphozytensubpopulationen bei Patienten mit ankylosierender Spondylitis und Gesunden

Who
12 patients with ankylosing spondylitis without acute inflammatory activity and 12 healthy people of similar age (Germany)
What
Single hyperthermic full bath (hot-water immersion) continued until sublingual body temperature reached 101.3 F (38.5 C); bath duration 50 minutes
Protocol
101.3 body-temperature target °F · 50 min · 1/wk
Measured
Serum cortisol, total lymphocytes and B, T, CD4 and CD8 subpopulations
Result
No significant change in cortisol, total lymphocytes or lymphocyte subpopulations over 4 hours, and no difference between patients and healthy controls; the authors conclude the benefit of hyperthermia in AS is probably not caused by a cortisol rise with immunosuppression
Limitations
Mechanistic outcomes only, no clinical endpoints; single session; 12 patients; German-language abstract (translated by us)

Protocols used in the studies

Randomized trial: 6 sessions of water-filtered infrared-A whole-body hyperthermia during an inpatient stay, added to physical therapy (session length and core target not given in the abstract). Infrared sauna: 8 sessions over 4 weeks (cabin temperature not given in abstract). Other mild whole-body hyperthermia studies targeted core temperatures of about 101.3-102.2 F (38.5-39 C) for 50-60 minutes, 1 to 9 sessions, by clinic device or hot bath; these are not saunas.

What is still unknown

No sham-controlled or sauna-specific randomized trial in axial spondyloarthritis; whether results with clinic hyperthermia devices transfer to conventional or infrared saunas; dose, durability beyond 6 months, and effects in highly active disease or during biologic therapy are unknown.

Safety

Cautions for sauna in this condition

  • No disease-activity flare was seen over a 4-week infrared-sauna course (PMID 18685882).
  • In the randomized hyperthermia trial, NSAID/analgesic use fell and the authors describe the treatment as well tolerated; adverse events were not itemized in the abstract (Lange 2017, DOI 10.1055/s-0042-116945).
  • Whole-body hyperthermia studies enrolled clinically inactive AS (PMID 19089489); effects in highly active disease are unstudied.
  • Next-day worsening of rheumatic pain after sauna is described, more in women and in non-inflammatory conditions; adequate cooling is advised (PMID 3265298).
  • General contraindications include unstable angina, recent myocardial infarction and severe aortic stenosis; avoid alcohol during sauna use (PMID 11165553). AS can involve aortic valve disease, so cardiac history should be reviewed.
General sauna safety and contraindications

For clinicians

Suggested rationale

In a randomized trial in AS, adding six sessions of water-filtered infrared whole-body hyperthermia to physical therapy gave greater pain relief and improvements in BASDAI and BASFI lasting up to 3-6 months (Lange 2017), and an infrared-sauna pilot showed within-session relief of pain and stiffness without disease flare (Oosterveld 2009); sauna-type heat may be considered as an adjunct to exercise-based care, recognizing that the trial was small, unblinded and used a clinic hyperthermia device rather than a sauna.

Suggested wording only. The treating clinician decides whether it reflects their clinical judgment for this patient.

Typical ICD-10 codes: M45.9, M45.A0. Examples only; the clinician assigns the code.

What a letter of medical necessity should containWho can write it: physicians, NPs, PAs and others